Publications by authors named "L Sarian"

Breast cancer (BC) remains a significant global health concern, with neoadjuvant chemotherapy (NACT) offering preoperative benefits like tumor downstaging and treatment response assessment. However, identifying factors influencing post-NACT treatment response and survival outcomes is challenging. Metabolomic approaches offer promising insights into understanding these outcomes.

View Article and Find Full Text PDF

Background: Neoadjuvant chemotherapy (NACT) has arisen as a treatment option for breast cancer (BC). However, the response to NACT is still unpredictable and dependent on cancer subtype. Metabolomics is a tool for predicting biomarkers and chemotherapy response.

View Article and Find Full Text PDF

Background: Neoadjuvant chemotherapy (NACT) is a treatment option for breast cancer patients that allows for the assessment of tumor response during treatment. This information can be used to adjust treatment and improve outcomes. However, the optimal imaging modalities and parameters for assessing tumor response to NACT are not well established.

View Article and Find Full Text PDF
Article Synopsis
  • A study was done to translate a questionnaire about body and sexual feelings after childbirth into Brazilian Portuguese for new mothers.
  • They surveyed 234 women who had given birth, either naturally or by C-section, to see how well the questionnaire worked for them.
  • The results showed that the questionnaire was reliable and could help understand the effects of perineal tears better, linking it to things like older age and urinary problems.
View Article and Find Full Text PDF

Objective: To compare the performance of the abdominal handheld point-of-care ultrasonography (POCUS) Butterfly-iQ to gold standard transvaginal ultrasonography (US) in identifying the position of intrauterine devices (IUDs) in the hands of a medical doctor specialised in ultrasonography.

Methods: In this diagnostic accuracy study, a single operator conducted abdominal POCUS followed by conventional transvaginal US. Seventy patients utilising copper or hormonal IUDs were assessed between June 2021 and October 2022.

View Article and Find Full Text PDF